Screener
Viridian Therapeutics, Inc. VRDN Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Change in fair value of derivative liability | (1,190) | — | 6,340 | — |
| Other income (expense), net | 156 | — | (516) | — |
| Total other income (expense), net | (851) | 6,032 | 10,417 | 12,986 |
| Net loss | $(127,119) | $(100,735) | $(232,020) | $(187,647) |
| Net loss per share, basic and diluted, common stock | $(1.05) | $(1.00) | $(1.95) | $(1.87) |
| Weighted-average common shares outstanding, basic and diluted | 107,884,104 | 81,593,463 | 105,063,550 | 81,471,496 |
| Net loss per share, basic and diluted, Series A convertible preferred stock | $(69.72) | $(66.99) | $(129.94) | $(124.93) |
| Weighted-average Series A convertible preferred shares outstanding, basic and diluted | 134,754 | 134,864 | 134,809 | 134,864 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s net income?
- Viridian Therapeutics, Inc. (VRDN) reported net income of -$127.12M in Q2 2026.
- How has Viridian Therapeutics, Inc.'s net income changed year-over-year?
- Viridian Therapeutics, Inc.'s net income decreased by 26.2% year-over-year, from -$100.74M to -$127.12M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s net income?
- Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s net income has grown at a 44.1% compound annual growth rate (CAGR), from -$79.41M to -$342.6M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Viridian Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude